期刊文献+

儿童暴发性肝衰竭人工肝治疗 被引量:4

Artificial liver support for fulminant hepatic failure in children
原文传递
导出
摘要 儿童暴发性肝衰竭的发病率还不明确,发生虽然少见,但短期内可以导致患儿因肝性脑病、弥散性血管内凝血(DIC)、多脏器衰竭等原因死亡。肝移植是其主要治疗方法,但长期肝源缺乏却限制了这一有效治疗。本文在介绍儿童暴发性肝衰竭的现状基础上,重点对人工肝技术的应用的效果评价进行探讨,认为人工肝对儿童暴发性肝衰竭治疗的作用举足轻重。根据人工肝的分类,主要讨论非生物型人工肝分子吸附循环系统(MARS)的应用,包括人工肝适应证和各种方法的优点和缺点。目前,人工肝治疗也面临许多问题,人工肝支持系统对患儿的治疗评估和研究尚不足,在改善生存方面尚未形成一致共识。 The true incidence of fulminant hepatic failure in the pediatric population is unknown, though fulminant hepatic failure is a rare but devastating syndrome (such as hepatic encepha- lopathy, DIC, MODS) that results in the death of most children affected. The mainstay of the treatment is liver transplantation, however, organ shortage limits its use.The purpose of this review is to introduce the current situation of fulminant liver failure in children, focusing on assessing the application of artificial liver, which is considered to play a pivotal role in the treatment of fulminant liver failure.According to its classification, we mainly discussed the application of non-biological artificial liver, in- cluding its indications, advantages and disadvantages, especially the MARS. At present, the artificial liver treatment also faces many problems. None of the ELS techniques has yet been eval- uated systematically in children, and survival benefits have not vet been demonstrated.
出处 《中国实用儿科杂志》 CSCD 北大核心 2014年第3期174-178,共5页 Chinese Journal of Practical Pediatrics
关键词 暴发性肝衰竭 儿童 人工肝 分子吸附循环系统 fulminant hepatic failure children artificial liversupport MARS
  • 相关文献

参考文献4

二级参考文献24

  • 1张建民,张学武,彭洪菊,方美云,王英德,席惠君,朱丽君.血浆置换治疗重度毒蕈中毒的疗效观察 (附9例报告)[J].大连医科大学学报,2001,23(2):108-109. 被引量:8
  • 2李兰娟.肝衰竭诊疗指南[J].中华内科杂志,2006,45(12):1053-1056. 被引量:101
  • 3张红宇.非生物型人工肝支持研究进展[J].透析与人工器官,2006,17(4):25-28. 被引量:1
  • 4中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝支持系统治疗肝衰竭指南(2009年).中华临床感染病杂志,:321-325.
  • 5Cochran JB, Losek JD. Acute liver failure in children [ J ]. Pediatr Emerg Care ,2007,23 (2) : 129 - 135.
  • 6Kobayashi N. Life support of artificial liver: Development of a bioartificial liver to treat liver failure [ J ]. J Hepatobiliary Pancreat Surg,2009 , 16(4) :113 - 117.
  • 7Takahashi K, Umehara Y, Umehara M, et al. Plasma exchange - based plasma recycling dialysis system as an artificial liver support[J]. Ther Apher Dial,2008,12 (4) :264 - 270.
  • 8Hessel FP, Bramlage P, Wasem J, et al. Cost -effectiveness of the artifi- cial liver support system MARS in patients with acute - on - chronic liver failure[J]. Eur J C, astroenterol Hepatol,2010,22( 2 ) :213 -220.
  • 9Gil HW, Kim SJ, Yang JO, et al. Clinical outcome of hemoperfusion in poisoned patients[J]. Blood Purif,2010,30(2) :84 -88.
  • 10Hirasawa H. Indications for blood purification in critical care[ J]. Contrib Nephrol,2010,166( 5 ) :21 -30.

共引文献41

同被引文献40

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部